Kardonat the L-carnitine – amino acids and their derivatives.
Indications
- Primary (congenital) insufficiency of a carnitine.
- Secondary insufficiency of a carnitine.
Structure
- active ingredient: levocarnitine; 200 mg contain
- 1 ml of solution a left carnitine;
- other components: Natrium benzoicum (E 211), malic acid, sodium saccharin, Pineapple fragrance, the water purified.
Contraindication
Hypersensitivity to medicament components.
Side reactions
from nervous system – infrequently: headache. Frequency is unknown: sudorogi1, dizziness.
tofrom heart – frequency is unknown: from heart consciousness.
from vessels – infrequently: arterial hypotension, arterial hypertension.
tofrom the respiratory system, bodies of a thorax and mediastinum – frequency is unknown: asthma.
from digestive tract – it is frequent: nausea, vomiting, diarrhea, abdominal pain. Infrequently: a dysgeusia, dyspepsia, dryness in a mouth.
from skin and hypodermic fabric – infrequently: abnormal smell of a body. Frequency is unknown: itching, rash.
Route of administration Medicine is intended toby
for oral administration. Before use solution should be dissolved in a glass of water and to accept in 30 minutes prior to food. To use the dosing syringe or a measured glass to a dosage. >
When using medicine it is reasonable to p to control levels of a free carnitine and acylcarnitine both in blood plasma, and in urine.
Dose and duration of treatment by a left carnitine are established by the doctor individually, depending on age, body weight and a nosological form of a disease of the patient.
Primary and secondary deficit of a carnitine
Dosage depends on specific congenital disbolism and weight of a condition of the patient during treatment.
generally, the recommended oral dose makes from 100 to 200 mg/kg/days
2–4 receptions, at less serious states the dose can be less (50–100 mk/kg/sut).
If clinical and biochemical signs do not improve, then the dose can be increased by the short period.
In acute metabolic disorders higher doses (up to 400 mg/kg/days) or intravenous administration of a left carnitine in a daily dose of 100 mg/kg can be required.
Secondary deficit of a carnitine at patients to whom carry out a hemodialysis.
byIf achieved considerable clinical results after the first course of intravenous administration, it is possible to perform maintenance therapy in a dose of 1 g/days by oral administration. In day of dialysis the oral administration of medicine is made after the procedure.
Maximum daily dosage for adults makes 6 g (30 ml).
Use during pregnancy or feeding by a breast
Adequate clinical trials with participation of pregnant women were not carried out by
Feature of use
. During pregnancy medicine should be applied if the advantage of its use for the woman exceeds potential risk for a fruit.Levokarnitin – a usual component of human milk. Use of a left carnitine to the nursing mothers was not studied. During feeding by a breast medicine should be applied if the advantage of its use for the woman prevails the potential risk for the child caused by excessive exposure of a carnitine.
ChildrenKARDONAT L-KARNITIN can apply
children (full-term and premature newborns) from first day of life. Ability to influence speed of response at control of motor transport or other mechanisms
does not influence.
OverdoseOverdose or prolonged use of a left carnitine can lead
to diarrhea. Levokarnitin easily leaves from blood plasma by dialysis. Interaction with other medicines and other types of interactions
Cannot exclude interaction between a left carnitine and medicaments of coumarin. Seldom or never reported about increase in the international normalized relation (INR) at simultaneous use of a left carnitine with coumarin drugs. At simultaneous use of these means it is necessary to carry out monitoring of MNV or to carry out other tests for coagulation every week to stabilization and monthly further.
Simultaneous use of a left carnitine with the means inducing a gipokarnitinemiya because of strengthening of removal of a carnitine kidneys (for example, the valproic acid, pro-medicaments containing pivalonovy acid, cephalosporins, Cisplatinum, karboplatin, ifosfamid), can reduce its level.
Storage conditionsto Store
at a temperature not over 25C. to Store
out of children's reach.
Characteristics | |
Active ingredients | L-carnitine |
Amount of active ingredient | 200 mg/ml |
Applicant | Sperko |
Code of automatic telephone exchange | A16AA01 Levokarnitin |
Interaction with food | To |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | container |
Producer | SPERKO UKRAINE |
Quantity in packing | 1 container |
Release form | solution for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Kardonat |
Kardonat a L-carnitine solution shouted. 200mg/ml Comte. 100 ml No. 1
- Product Code: 180586
- In Stock
- Ready to ship
-
$28.58